To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT05814393 · COMPLETED
Trial details
- NCT number
- NCT05814393
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-03
- Primary completion
- 2024-05-14
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.